Ascendia

  MARKET NEWS

Sirio Pharma to Introduce First-in-Market Lutein Soft Chew for Eye Health
Thermo Fisher Scientific Expands Real-World Data Interoperability & Linkage Through Strategic Collaboration With Datavant
Calla Lily Clinical Care & Merck Announce Strategic Collaboration to Advance Intravaginal Drug Delivery Platform
Eliquis Sales to Fall as European Patent Expiry Nears
MIMETAS & Partners Launch World’s First Microphysiological Systems Industry Alliance
Evogene Announces Expanded Collaboration With Google Cloud to Integrate AI Agents Into ChemPass AI
Synthace Collaborates With Charles River to Offer Global Pharma Industry More Robust, Faster & Cost-Effective Assays
SPT Labtech & BellBrook Labs Introduce High-Throughput Screening Platform for Cancer Research
Sobi Completes Acquisition of Arthrosi Therapeutics, Strengthening Pipeline Potential Treatment of Gout
Evinova & Bristol Myers Squibb Forge Strategic Collaboration to Optimize Clinical Development With Artificial Intelligence

  EXPERT CONTENT & RESOURCES

How Can a Stage-Based Program to Determine HME Applicability Benefit Your API?

How Can a Stage-Based Program to Determine HME Applicability Benefit Your API?

Low bioavailability due to poor API solubility is one of the major challenges to be overcome when developing oral dosage form drug products. An effective way of addressing this problem is to transform low solubility APIs into amorphous solid dispersions (ASDs) and can often be achieved via hot melt extrusion (HME).

Antibody Validation: The Hidden Key to Reproducible Drug Discovery

Antibody Validation: The Hidden Key to Reproducible Drug Discovery

As research grows more complex and data-driven, rigorous antibody validation is increasingly recognized as a critical requirement for ensuring data integrity and improving the predictive power of drug discovery pipelines.

Dr. Joseph Sinkule, Founder, Chairman of the Board and CEO of Klotho Neurosciences

Klotho Neurosciences: Focused on Neurodegenerative & Age-Related Disorders

Dr. Joseph Sinkule, CEO of Klotho Neurosciences, discusses the company, its therapies, the human Klotho gene, and longevity.

  FEATURED EDITORIAL

  COMPANY PROFILE

West is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of lifesaving and life-enhancing medicines for patients. We  are guided by our core values of Passion for Customers, Leadership in Quality and One West team and these values underpin our purpose to improve patient’s lives. With a century of experience, we work together with our customers to support patient health and fuel a brighter future with product innovation. West works by the side of customers from concept to patient to develop products that promote the efficiency, reliability and safety of the world’s pharmaceutical drug supply. Click here for more.

  WHITEPAPERS & WEBINARS

WHITEPAPER - How to Mitigate Risk for Biologics During Fill/Finish Manufacturing

WHITEPAPER - How to Mitigate Risk for Biologics During Fill/Finish Manufacturing

Aseptic processing with the highest degree of sterility assurance, filling accuracy, and quality is critical for high-value, small-batch therapies. This white paper explores the specialized equipment, expertise, and services needed for efficient biologics fill/finish manufacturing.

CLICK HERE TO DOWNLOAD/VIEW THE …

WHITEPAPER - Extrusion-Spheronization, Engineered for Today’s Controlled Release Forms

WHITEPAPER - Extrusion-Spheronization, Engineered for Today’s Controlled Release Forms

 

Synchronizing and controlling API delivery, Extrusion-Spheronization (E-S) offers pharmaceutical drug developers a robust technique to develop and manufacture today’s most complex oral sold dose therapeutics.

Manufacturing oral solid dose API’s into spheres via Extrusion-Spheronization is not new. What is …

WHITEPAPER - Unique Manufacturing Challenges Associated With Sterile Eye Ointments

WHITEPAPER - Unique Manufacturing Challenges Associated With Sterile Eye Ointments

The manufacture of ophthalmic ointments is much more complex than the production of ocular liquid therapies and presents several unique challenges. It is essential for drug developers to choose outsourcing partners with extensive manufacturing experience with these specialized capabilities in …

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

February 18 – Formulation Development
February 25 – ODT/Fast Dissolve